Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis

Completed

Conditions studied: MRSA Infections

In brief

This study prospectively selects the patients to examine the effectiveness of the investigators' current standard of prophylaxis prior to vascular surgery and to compare the effectiveness of vancomycin and daptomycin plus cefazolin in reducing infections in vascular surgical patients.

Key facts

Study ID

NCT00967941

Run by

CAMC Health System

People needed

169

Starts

2007-08-01

Expected to finish

2010-08-01

Last updated by the study team

2020-02-28

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patients greater than 18 years of age undergoing vascular surgery including carotid procedures and a vascular access procedure (Fistula or Graft).

You may not qualify if…

• Patients with an allergy to daptomycin or vancomycin.
• Patients with chronic wounds.
• Prior colonization of MRSA.
• Increased MRSA rate facility wide.
• Continuous inpatient stay >27 hrs prior to surgical procedure.
• Patients with active infection requiring antibiotics preoperatively.
• Patients with a history of MRSA colonization or infection, HIV, admission for >3 months in an acute care center or long-term care center, penicillin allergy or penicillin allergy and on dialysis.
• Dialysis patients.

Where it is running

• Vascular Center of Excellence — Charleston, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.